Cormark Has Negative Outlook of Curaleaf FY2025 Earnings

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Free Report) - Analysts at Cormark reduced their FY2025 earnings estimates for shares of Curaleaf in a research report issued to clients and investors on Wednesday, March 5th. Cormark analyst J. Pytlak now forecasts that the company will post earnings of ($0.23) per share for the year, down from their previous estimate of ($0.19). The consensus estimate for Curaleaf's current full-year earnings is ($0.25) per share. Cormark also issued estimates for Curaleaf's FY2026 earnings at ($0.16) EPS.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its quarterly earnings data on Monday, March 3rd. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.09. The firm had revenue of $331.05 million for the quarter, compared to analysts' expectations of $331.87 million. Curaleaf had a negative net margin of 14.82% and a negative return on equity of 13.67%.

Curaleaf Price Performance

Shares of CURLF traded down $0.02 on Monday, hitting $0.99. The company's stock had a trading volume of 985,502 shares, compared to its average volume of 748,980. The company has a market capitalization of $654.02 million, a PE ratio of -3.41 and a beta of 0.57. Curaleaf has a fifty-two week low of $0.88 and a fifty-two week high of $6.40. The company has a 50 day moving average price of $1.41 and a 200 day moving average price of $2.13. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.11 and a quick ratio of 0.51.

Remove Ads

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.